Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2.

Innate CD1d-restricted natural killer T (NKT) cells are infected and lost in HIV-1-infected patients, and this could contribute to HIV-1 pathogenesis because NKT cells play an important role in directing both adaptive and innate immunity. Administration of interleukin-2 (IL-2) to HIV-1-infected patients leads to substantial and sustained CD4+ T-cell expansion, involving both naive and memory cells. We investigated whether IL-2 treatment could restore the NKT cell compartment in patients with primary HIV-1 infection. We show that IL-2 combined with effective antiretroviral therapy (ART) resulted in significant expansion of CD1d-restricted NKT cells. Expansion occurred in both the CD4- and CD4+ subsets of NKT cells, and expanded cells expressed the CD161 maturation marker while expression of the HIV coreceptor CCR5 was reduced. These data indicate that IL-2 treatment in combination with effective ART is beneficial for the restoration of innate NKT cell immunity in patients with primary HIV-1 infection.

[1]  Guido Silvestri,et al.  Viral and host factors in the pathogenesis of HIV infection. , 2005, Current opinion in immunology.

[2]  H. Ljunggren,et al.  Development and function of CD1d-restricted NKT cells: influence of sphingolipids, SAP and sex. , 2005, Trends in immunology.

[3]  J. Metcalf,et al.  In vivo expansion of CD4+CD45RO–CD25+ T cells expressing foxP3 in IL-2-treated HIV-infected patients , 2005 .

[4]  Sebastian Bonhoeffer,et al.  The HIV coreceptor switch: a population dynamical perspective. , 2005, Trends in microbiology.

[5]  D. Pellicci,et al.  Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples , 2005, European journal of immunology.

[6]  K. Weinberg,et al.  Distinct homeostatic requirements of CD4+ and CD4- subsets of Valpha24-invariant natural killer T cells in humans. , 2004, Blood.

[7]  M. Kronenberg,et al.  Going both ways: immune regulation via CD1d-dependent NKT cells. , 2004, The Journal of clinical investigation.

[8]  R. Lempicki,et al.  IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. , 2004, Blood.

[9]  D. Nixon,et al.  Development of innate CD4+ α-chain variable gene segment 24 (Vα24) natural killer T cells in the early human fetal thymus is regulated by IL-7 , 2004 .

[10]  D. Follmann,et al.  Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection. , 2004, Blood.

[11]  D. Nixon,et al.  Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Vα24 NKT cell compartment , 2003, European journal of immunology.

[12]  É. Oksenhendler,et al.  Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial , 2003, AIDS.

[13]  D. Nixon,et al.  Selective Loss of Innate CD4+ Vα24 Natural Killer T Cells in Human Immunodeficiency Virus Infection , 2002, Journal of Virology.

[14]  R. Lempicki,et al.  Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Michael P Busch,et al.  Use of laboratory tests and clinical symptoms for identification of primary HIV infection , 2002, AIDS.

[16]  D. Haas,et al.  CD1d-restricted Human Natural Killer T Cells Are Highly Susceptible to Human Immunodeficiency Virus 1 Infection , 2002, The Journal of experimental medicine.

[17]  G. Giaccone,et al.  Selective Decrease in Circulating Vα24+Vβ11+ NKT Cells During HIV Type 1 Infection1 , 2002, The Journal of Immunology.

[18]  J. Metcalf,et al.  Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. , 1996, The New England journal of medicine.

[19]  S. Balk,et al.  Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain , 1993, The Journal of experimental medicine.

[20]  J. Metcalf,et al.  In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. , 2005, The Journal of clinical investigation.

[21]  D. Nixon,et al.  Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Dybul,et al.  Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection. , 2002, The Journal of infectious diseases.

[23]  G. Giaccone,et al.  Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. , 2002, Journal of Immunology.